Shares of Vertex Pharmaceuticals Inc.
inched 0.24% higher to $188.86 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index
rising 0.85% to 4,480.70 and the Dow Jones Industrial Average
rising 0.68% to 34,814.39. Vertex Pharmaceuticals Inc. closed $92.13 below its 52-week high ($280.99), which the company reached on October 13th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson
rose 0.38% to $165.42, Merck & Co. Inc.
rose 0.97% to $72.81, and AbbVie Inc.
rose 1.21% to $107.77. Trading volume (1.6 M) remained 279,488 below its 50-day average volume of 1.9 M.